Skip to main content
Caplight Logo









Magnus Medical

Magnus Medical

Private
Burlingame, CaliforniaHealthcare & Life Scienceshttps://www.magnusmedical.com/

Last Round

Early Stage

VC

May 26, 2026

Total Funding Raised

$90.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Magnus Medical is a neurotechnology company that develops non-invasive brain stimulation solutions for treating neurological and psychiatric disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

transcranial magnetic stimulationTMSneuromodulationtreatment-resistant depressionTRDmajor depressive disorderMDDpersonalized neurostimulationMRI-guided TMSaccelerated TMSbrain stimulationintermittent theta-burst stimulationiTBSmental health technologynew technology add-on paymentNTAPCPT codes

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Magnus Medical Comparables

Compare Magnus Medical with similar companies based on industry and business-model similarity.

Magnus Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BrainsWay Ltd.
79%
Magstim
77%
Neuronetics Inc
74%

Magnus Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCMay 26, 2026
Series BMay 9, 2025
Series AOct 29, 2021
GrantSep 15, 2020

Magnus Medical Investors

Notable investors and investment history

Magnus Medical investors
InvestorRounds
National Institute of Mental HealthGrant
Dolby Family VenturesSeries B
Khosla VenturesSeries B
NIH RADxGrant
JAZZ Venture PartnersSeries B, Series A
Mubadala Investment CompanySeries B
Red Tree Venture CapitalSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 26, 2026

    $49M raised in early stage VC round

  • Oct 1, 2025

    SAINT® therapy is now FDA authorized for treatment-resistant depression.

Magnus Medical Filings

Explore SEC and related filing metadata, where available.

Magnus Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Magnus Medical's valuation, stock price, and market status.

Is Magnus Medical a public or private company?

Magnus Medical is a private company.

What is the current stock price of Magnus Medical?

Magnus Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Magnus Medical worth (valuation)?

Valuation information for Magnus Medical is not publicly available.

Can I buy Magnus Medical stock?

Magnus Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Magnus Medical's last funding round?

Magnus Medical's most recent funding round was Early Stage VC on May 26, 2026.

Who are the main investors in Magnus Medical?

Key investors in Magnus Medical include JAZZ Venture Partners, Red Tree Venture Capital.

Will Magnus Medical IPO soon?

No public IPO plans have been announced for Magnus Medical.

How can I track Magnus Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Magnus Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBurlingame, California
Employee Range68
Year Founded2020
Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?